New York, New York–(Newsfile Corp. – January 6, 2025) – The legislation agency of Kirby (NYSE:) McInerney LLP publicizes {that a} class motion lawsuit has been filed within the U.S. District Courtroom for the Center District of Tennessee on behalf of those that acquired Revance Therapeutics (NASDAQ:), Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) securities throughout the interval from February 29, 2024, by way of December 6, 2024 (“the Class Period”). Traders have till March 4, 2025, to use to the Courtroom to be appointed as lead plaintiff within the lawsuit.
[LEARN MORE ABOUT THE CLASS ACTION]
Previous to the Class Interval, in January 2020, Revance entered right into a distribution settlement (the “Distribution Agreement”) with Teoxane SA (“Teoxane”), pursuant to which Teoxane granted Revance the unique proper to import, market, promote, promote, and distribute Teoxane’s line of Resilient Hyaluronic Acid dermal fillers, in alternate for two,500,000 shares of Revance frequent inventory. As well as, beneath the Distribution Settlement, Revance is required to satisfy sure minimal buy obligations and sure minimal expenditure necessities and both social gathering could terminate the Distribution Settlement within the occasion of “a material breach by the other party.”
In August 2024, Revance and Crown Laboratories, Inc. (“Crown”), a privately held marketer and producer of skincare merchandise, collectively introduced that they’d entered right into a merger settlement (the “Merger Agreement”). Underneath the phrases of the Merger Settlement, Crown would begin a young supply (the “Tender Offer”) to accumulate all excellent shares of Revance’s frequent inventory for $6.66 per share in money, representing a complete enterprise worth of $924 million.
On September 23, 2024, Revance disclosed in an SEC submitting that it “received a notice to remedy alleged material breaches, including breaches of the maximum level of buffer stock and required efforts to promote and sell Teoxane products, under the Company’s exclusive distribution agreement with Teoxane SA.” Because of the dispute with Teoxane, Revance suggested that Crown’s Tender Supply had been delayed till a minimum of October 4, 2024. On this information, the price of Revance shares declined by $0.45 per share, or 7.66%, from $5.81 per share on September 20, 2024, to shut at $5.36 on September 23, 2024.
Then, on December 9, 2024, Revance disclosed in an SEC submitting that Crown and Revance had amended their merger settlement, and that Crown would shortly begin a young supply to accumulate all excellent shares of Revance’s frequent inventory for $3.10 per share in money – a discount of over 50% from the previously-announced buy price. On this information, the price of Revance shares declined by $0.79 per share, or roughly 20.68%, from $3.82 per share on December 6, 2024, to shut at $3.82 on December 9, 2024.
The grievance alleges that defendants, all through the Class Interval, made false and/or deceptive statements and/or didn’t disclose that: (1) Revance was in materials breach of the Distribution Settlement; (2) the foregoing subjected the Firm to an elevated danger of litigation, in addition to financial and reputational hurt; and (3) all of the foregoing elevated the danger that the Tender Supply can be delayed and/or amended.
Should you bought or in any other case acquired Revance securities, have info, or want to study extra about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by e mail at investigations@kmllp.com, or fill out the contact type beneath, to debate your rights or pursuits with respect to those issues with none value to you.
[CONTACT FORM]
Kirby McInerney LLP is a New York-based plaintiffs’ legislation agency concentrating in securities, antitrust, whistleblower, and client litigation. The agency’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of {dollars}. Extra details about the agency could be discovered at Kirby McInerney LLP’s web site.
This press release could also be thought-about Legal professional Promoting in some jurisdictions beneath the relevant legislation and moral guidelines.
To view the supply model of this press release, please go to https://www.newsfilecorp.com/launch/236193